Approvals/TGA/MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe

Approved

STANDARD

MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe

Stada Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b1706aee3538e142
Product Name: MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe
Artg Id: 129948
Artg Name: MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe
Sponsor: Stada Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/stada-pharmaceuticals-australia-pty-limited
Artg Date: 2008-08-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/502d9dba92da781794ba9933445d3c2c.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e1f151ca780d1fb09e2d292f81654e47.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b1706aee3538e142

Type

Standard